TBL-1108MS

N/A

Report date: 2025/01/26 16:34:10

Base Information

Drug NameTBL-1108MS
Drug Alias Namemultiple sclerosis therapy (Transgene Biotek)TBL-1108MS
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulatorsB-lymphocyte inhibitors
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransgene Biotek Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTransgene Biotek Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A